🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to learn more about the effects of switc...
Status
Active Not Recruiting
Location
Be Well Medical Center
Start Date
2022-08-16
Trial ID
NCT05502341
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-19
Trial ID
NCT01227824
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
This study will compare safety, efficacy, and tolerability of a two drug re...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-18
Trial ID
NCT02831764
Treatments Being Tested
i2-D²EFT substudy is an observational cohort nested within the parent D²EFT...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-02-01
Trial ID
NCT04183738
Treatments Being Tested
This is a phase IV, open label, multicentre trial that will be taking place...
Status
Unknown
Location
Chelsea and Westminster Hospital
Start Date
2014-11
Trial ID
NCT02285374
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of a fixed ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-11-13
Trial ID
NCT02607930
Treatments Being Tested
The LATA trial will find out if taking a long-acting injectable form of HIV...
Status
Unknown
Location
Moi University
Start Date
2023-06-22
Trial ID
NCT05154747
Treatments Being Tested
This is a phase 2b, randomized, multicenter, parallel group, partially blin...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-11-18
Trial ID
NCT04493216
Treatments Being Tested